Galanin, galantide and galanin(1-14)-[α-aminobutyric acid8]-scyliorhinin-I: Structure dependent effects on the rat isolated gastric fundus

Pharmacological Research

Volumn 35, Issue 1, 1997, Pages 7-16

  Korolkiewicz, R ^b   Sliwinski W ^b   Rekowski, P ^a   Halama Borowiec, A ^b   Mucha, P ^a   Szczurowicz, A ^b   Korolkiewicz, K Z ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b NONE

Author keywords

Galanin; Galantide; Gastric smooth muscle; Rats

Indexed keywords

GALANIN; GALANIN (1,14) [ALPHA AMINOBUTYRIC ACID] SCYLIORHININ I; GALANIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STOMACH FUNDUS; STOMACH MUSCLE; SWINE;

EID: 0030966412     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0099     Document Type: Article

References (46)

1. 1. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V. Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-8.
2. 2. Amiranoff B, Servin Al, Rouyer-Fessard C, Couvineau A, Tatemoto K, Laburthe M. Galanin receptors in a hamster pancreatic β-cell tumor: identification and molecular characterization. Endocrinology 1987; 121: 284-9.
3. 3. Bartfai T. Galanin: A neuropeptide with important central nervous system action. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology. The fourth generation of progress. New York: Raven Press Ltd. 1995: 563-71.
4. 4. Ekblad E, Hakanson R, Sundler F, Wahlestedt C. Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol 1985; 86: 241-6.
5. 5. Melander T, Hökfelt T, Rökaeus A, Fahrenkrug J, Tatemoto K, Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tiss Res 1985; 239: 253-70.
6. 6. Rökaeus A. Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci 1987; 10: 158-64.
7. 7. Bersani M, Johnsen AH, Hojrup P, Dunning BE, Andreasen JJ, Holst JJ. Human galanin: primary structure and identification of two molecular forms. FEBS Lett 1991; 283: 189-94.
8. 8. Norberg AR, Sillard M, Carlquist H, Jornvall, Mutt V. Chemical detection of natural peptides by specific structures. Isolation of chicken galanin by monitoring for its N-terminal dipeptide, and determination of the amino acid sequence. FEBS Lett 1991; 228: 151-3.
9. 9. Yanaihara N, Yanaihara C, Hoshino M, Mochizuki T, Iguchi K. Immunochemical and biochemical properties of purposely designed synthetic peptides. Ann NY Acad Sci 1988; 527: 29-43.
10. 10. Katsoulis S, Schmidt WE, Schwörer H, Creutzfelt W. Effects of galanin, its analogues and fragments on rat isolated fundus strips. Br J Pharmacol 1990; 101: 297-300.
11. 11. Rossowski WJ, Rossowski TM, Zacharia S, Ertan A, Coy DH. Galanin binding sites in rat gastric and jejunal smooth muscle membranes preparations. Peptides 1990; 11: 333-8.
12. 12. Katsoulis S, Clemens A, Mory-Wortmann C, Schwörer H, Schaube H, Klomp H-J, Fölsch UR, Schmidt WE. Human galanin modulates human chronic motility in vitro. Characterization of structural requirements. Scand J Gastroenterol 1995; 31: 446-51.
13. 13. Fox JET, McDonald TJ, Kostolanska F, Tatemoto K. Galanin: an inhibitory neural peptide in the canine small intestine. Life Sci 1986; 39: 103-10.
14. 14. Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L. Galanin contracts and relaxes guinea pig and canine intestinal smooth muscle cells through distinct receptors. Gastroenterology 1995; 108: 3-11.
15. 15. Brown DR, Hildebrand KR, Parsons AM, Soldani G. Effects of galanin on smooth muscle and mucosa of porcine jejunum. Peptides 1990; 11: 497-500.
16. 16. Fox JET, Brooks B, McDonald TJ. Actions of galanin fragments on rat, guinea pig and canine intestinal motility. Peptides 1988; 9: 1183-9.
17. 17. Delvaux M, Botella A, Fiormonti J, Frexinos J, Bueno L. Galanin induces contraction of smooth muscle from pig ileum by a direct myogenic effect. Reg Pept 1990; 11: 497-500.
18. 18. Harling H, Gregersen H, Rasmussen TN, Poulsen SS, Holst JJ, Jensen SL. Galanin: distribution and effect on contractile activity and release of vasoactive intestinal polypeptide from the isolated perfused porcine ileum. Digestion 1990; 47: 191-9.
19. 19. Kuwahara A, Ozaki T, Yanaihara N. Structural requirements for galanin action in the guinea-pig ileum. Regul Pept 1990; 29: 23-9.
20. 20. Chen CK, McDonald TJ, Daniel EE. Characterization of galanin receptor in canine small intestinal circular muscle synaptosomes. Am J Physiol 1994; 266: G106-12.
21. 21. Śliwiński W, Korolkiewicz R, Rekowski P, Halama A, Korolkiewicz K. Actions of galanin and some of its analogues on rat isolated gastric fundus. Fundam Clin Pharmacol 1996; 10: 442-9.
22. 22. Bartfai T, Bedecs K, Land T, Langel U, Bertorelli R, Girotti P, Consolo S, Xy X, Wiesenfeld-Hallin Z, Nilsson S, Pieribone VA, Hökfelt T. M-15: High-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci USA 1991; 88: 10961-5.
23. 23. Wiesenfeld-Hallin Z, Xu XJ, Langel U, Bedecs K, Hökfelt T, Bartfai T. Galanin-mediated control of pain: enhanced role after nerve injury. Proc Natl Acad Sci USA 1991; 88: 10961-5.
24. 24. Lindskog S, Ahren B, Land T, Langel U, Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992; 210: 183-8.
25. 25. Gu Z-FA, Rossowski WJ, Coy DH, Pradhan TK, Jensen RT. Chimeric galanin analogues that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther 1993; 266: 912-8.
26. 26. Vane JR. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol 1957; 12: 344-9.
27. 27. Rekowski P, Halama A, Mucha P, Kupryszewski G, Poćwiardowska E, Korolkiewicz KZ. Galanin and its analogues: synthesis and studies of their agonist activity on smooth muscles. Pol J Chem 1993; 67: 233-44.
28. 28. Conlon JM, Deacon CF, O'Toole L, Thim L. Scyliorhinin I and II: two novel tachykinins from dogfish gut. FEBS Lett 1986; 200: 111-6.
29. 29. Rolka K, Kupryszewski G, Janas P, Myszor J, Herman ZS. Synthesis and biological activity in GPI test of scyliorhinin I and its analogues modified in position 8 by Leu, Sar and Pro residues. Collect Czech Chem Commun 1991; 56: 1957-62.
30. 30. Tallrida RJ, Murray RB. Manual of pharmacologic calculations with computer programs, 2nd edition, New York: Springer Verlag. 1986.
31. 31. Barlow RB. In: Biodata handling with microcomputers. Programs written in BASIC for handling biological, biochemical, pharmacological and physicochemical results-with a commentary on the calculations involved. Amsterdam: Elsevier Publishers BV. 1983.
32. 32. Bennet A, Stamford IF, Sanger GJ, Bloom SR. The effects of various peptides on human isolated gut muscle. J Pharm Pharmacol 1992; 44: 960-7.
33. 33. Tallarida RJ, Raffa RB, McGonigle P. Radioligand binding. Direct binding. Hill plot. In: Tallarida RJ, Raffa RB, McGonigle P, eds. Principles in general pharmacology, New York: Springer Verlag. 1988: 211-4.
34. 34. Laurence D, Carpenter J. A dictionary of pharmacology and clinical drug evaluation. London: UCL Press. 1994: 102.
35. 35. Rossowski WJ, Zacharia S, Jiang N-Y, Mungan Z, Mills M, Ertan A, Coy DH. Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction. Eur J Pharmacol 1993; 240: 259-67.
36. 36. Hermansen K, Yanaihara N, Ahren B. On the nature of the galanin action on the endocrine pancreas: studies with six galanin fragments in the perfused dog pancreas. Acta Endocrinol 1989; 121: 545-50.
37. 37. Lagny-Pourmir I, Lorinet Am, Yanaihara N, Laburthe M. Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat. Peptides 1989; 10(4): 757-61.
38. 38. Amiranoff B, Lorinet A-M, Yanaihara N, Laburthe M. Structural requirements for galanin action in the pancreatic β cell line Rin m 5F. Eur J Pharmacol 1989; 163: 205-7.
39. 39. Mungan Z, Ozmen V, Ertan A, Coy DH, Baylor LM, Rice JC, Rossowski WJ. Structural requirements for galanin inhibition of pentagastrin-stimulated gastric acid secretion in conscious rats. Eur J Pharmacol 1992; 214: 53-7.
40. 40. Korolkiewicz R, Śliwiński W, Rekowski P, Halama A, Mucha P, Szczurowicz A, Guzowski P, Korolkiewicz KZ. Contractile action of galanin analogues on rat isolated gastric fundus strips is modulated by tachyphylaxis to substance P. Pharmacol Res 1996.
41. 3 receptors. Eur J Pharmacol 1993; 250: 311-6.
42. 42. Fisone G, Langel M, Carlquist T, Bergman S, Consolo S, Hökfelt A, Unden A, Andell S, Bartfai T. Galanin receptor and its ligands in the rat hippocampus. Eur J Biochem 1989; 181: 269-76.
43. 43. Frandsen EK, Gronvald FC, Heding LG, Johansen NL, Lundt BF, Moody AJ, Markussen J, Volund A. Glucagon: structure-function relationships investigated by sequence deletions. Hoppe-Seyler's Z Physiol Chem 1981; 362: 665-77.
44. 44. Couvineau AC, Rouyer-Fessard A, Fournier A, St Pierre S, Pipkorn R, Laburthe M. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effects of nine partial sequences. Biochem Biophys Res Commun 1984; 121: 493-8.
45. 45. Mutt V. Cholecystokinin: isolation, structure and function. In: Glass, J, G.P. Ed. Gastrointestinal hormones. New York: Raven Press. 1980: 169-222.
46. 46. Kitabgi P, Poustis C, Granier C, Van Rietschoten J, Rivier J, Morgat JL, Freychet P. Neurotensin binding to extraneural and neural receptor: comparison with biological activity and structure-activity relationships. Mol Pharmacol 1980; 18: 11-7.